Bicycle Therapeutics PLC (BCYC)
22.89
-0.69
(-2.93%)
USD |
NASDAQ |
May 10, 16:00
22.80
-0.09
(-0.39%)
After-Hours: 20:00
Bicycle Therapeutics Cash from Operations (TTM): -85.09M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -85.09M |
December 31, 2023 | -60.63M |
September 30, 2023 | -43.65M |
June 30, 2023 | -48.50M |
March 31, 2023 | -106.12M |
December 31, 2022 | -86.11M |
September 30, 2022 | -66.24M |
June 30, 2022 | -38.65M |
March 31, 2022 | -27.49M |
December 31, 2021 | -14.79M |
September 30, 2021 | -20.98M |
Date | Value |
---|---|
June 30, 2021 | -52.68M |
March 31, 2021 | -52.66M |
December 31, 2020 | -17.79M |
September 30, 2020 | -6.091M |
June 30, 2020 | -6.991M |
March 31, 2020 | -2.25M |
December 31, 2019 | -28.61M |
September 30, 2019 | -32.55M |
June 30, 2019 | -26.32M |
March 31, 2019 | -24.01M |
December 31, 2018 | -26.08M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-106.12M
Minimum
Mar 2023
-2.25M
Maximum
Mar 2020
-41.21M
Average
-35.60M
Median
Cash from Operations (TTM) Benchmarks
Biodexa Pharmaceuticals Plc | -8.515M |
NuCana PLC | -32.90M |
TC BioPharm (Holdings) PLC | -13.16M |
Adaptimmune Therapeutics PLC | -140.88M |
Verona Pharma PLC | -50.22M |